Abstract:Clustering of glial cells around amyloid‐β plaques is a well‐known hallmark of Alzheimer's disease (AD) neuropathology, but it is unclear what triggers this glial response and whether the response is beneficial or detrimental. This study investigates clustering and phenotype of glial cells around neuritic plaques (NP) and non‐neuritic plaques (non‐NP) during the progression of Alzheimer's disease neuropathologic change (ADNC). We demonstrate that microglia and astrocytes preferentially cluster around p‐tau+ NP with brain region‐specific differences between hippocampus and frontal cortex. This close association of the neuroimmune response with NP during ADNC progression underscores the central role of NP in AD. Neuroinflammation plays an important role in the pathological cascade of Alzheimer's disease (AD) along with aggregation of extracellular amyloid‐β (Aβ) plaques and intracellular aggregates of tau protein. In animal models of amyloidosis, local immune activation is centered around Aβ plaques, which are usually of uniform morphology, dependent on the transgenic model used. In postmortem human brains a diversity of Aβ plaque morphologies is seen including diffuse plaques (non‐neuritic plaques, non‐NP), dense‐core plaques, cotton‐wool plaques, and NP. In a recent study, we demonstrated that during the progression of Alzheimer's disease neuropathologic changes (ADNC), a transformation of non‐NP into NP occurs which is tightly linked to the emergence of cortical, but not hippocampal neurofibrillary tangle (NFT) pathology. This highlights the central role of NP in AD pathogenesis as well as brain region‐specific differences in NP formation. In order to correlate the transformation of plaque types with local immune activation, we quantified the clustering and phenotype of microglia and accumulation of astrocytes around non‐NP and NP during the progression of ADNC. We hypothesize that glial clustering occurs in response to formation of neuritic dystrophy around NP. First, we show that Iba1‐positive microglia preferentially cluster around NP. Utilizing microglia phenotypic markers, we furthermore demonstrate that CD68‐positive phagocytic microglia show a strong preference to cluster around NP in both the hippocampus and frontal cortex. A similar preferential clustering is observed for CD11c and ferritin‐positive microglia in the frontal cortex, while this preference is less pronounced in the hippocampus, highlighting differences between hippocampal and cortical Aβ plaques. Glial fibrillary acidic protein‐positive astrocytes showed a clear preference for clustering around NP in both the frontal cortex and hippocampus. These data support the notion that NP are intimately associated with the neuroimmune response in AD and underscore the importance of the interplay of protein deposits and the immune system in the pathophysiology of AD.

Pretangle pathology within cholinergic nucleus basalis neurons coincides with neurotrophic and neurotransmitter receptor gene dysregulation during the progression of Alzheimer's disease

Protein homeostasis gene dysregulation in pretangle-bearing nucleus basalis neurons during the progression of Alzheimer's disease.

Resilience of Precuneus Neurotrophic Signaling Pathways Despite Amyloid Pathology in Prodromal Alzheimer’s Disease

Tau pathology epigenetically remodels the neuron-glial cross-talk in Alzheimer's disease

Tau pathology epigenetically remodels the neuron-glial cross-talk in Alzheimer’s disease

Brain-derived neurotrophic factor (BDNF) and TrkB hippocampal gene expression are putative predictors of neuritic plaque and neurofibrillary tangle pathology.

Transformation of non-neuritic into neuritic plaques during AD progression drives cortical spread of tau pathology via regenerative failure

Neuron-specific alterations in signal transduction pathways associated with Alzheimer's disease.

Expression Profiling of Precuneus Layer III Cathepsin D‐immunopositive Pyramidal Neurons in Mild Cognitive Impairment and Alzheimer's Disease: Evidence for Neuronal Signaling Vulnerability

Hippocampal Prongf Signaling Pathways and Β-Amyloid Levels in Mild Cognitive Impairment and Alzheimer Disease.

Protein tau phosphorylation in the proline rich region and its implication in the progression of Alzheimer's disease

Preferential clustering of microglia and astrocytes around neuritic plaques during progression of Alzheimer's disease neuropathological changes

Perineuronal net deglycosylation associates with tauopathy‐induced gliosis and neurodegeneration

Single-nucleus and spatial transcriptomic profiling of human temporal cortex and white matter reveals novel associations with AD pathology

Rac1b Increases with Progressive Tau Pathology Within Cholinergic Nucleus Basalis Neurons in Alzheimer's Disease

Consequences of Pathogenic Tau Expression in Mouse Locus Coeruleus

Maturation of neuronal AD-tau pathology involves site-specific phosphorylation of cytoplasmic and synaptic tau preceding conformational change and fibril formation

A cell autonomous regulator of neuronal excitability modulates tau in Alzheimer's disease vulnerable neurons

Accumulation of pTau231 at the Postsynaptic Density in Early Alzheimer's Disease

Tau pathology in the dorsal raphe may be a prodromal indicator of Alzheimer's disease

Oligomeric, phosphorylated, and truncated tau and spliceosome pathology within the entorhinal-hippocampal connectome across stages of Alzheimer's disease